CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer is a research paper published in UNC Libraries (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3UG1CA233339-06S1
Washington University/Siteman Cancer Center Lead Academic Site
National Institutes of Health
Grant: 5UG1CA233327-05
UG1 - NCTN (Network Lead)
National Institutes of Health
Grant: 1UG1CA233373-01
UNC Lead Academic Participating Site
National Institutes of Health
Grant: 5P50CA058223-12
SPORE in Breast Cancer
National Institutes of Health
Grant: 6UG1CA189858-08
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)
National Institutes of Health
Grant: 5P30CA033572-27
Developmental Funds
National Institutes of Health
Grant: 3UG1CA233290-06S1
Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center
National Institutes of Health
Grant: 5UG1CA233180-02
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
National Institutes of Health
Grant: 1UG1CA233253-01
NCI National Clinical Trials Network (UG1)
National Institutes of Health
Grant: 3U24CA196171-04S1
THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE
National Institutes of Health
Grant: 5U10CA180882-02
Statistics and Data Center for the Alliance for Clinical Trials in Oncology
National Institutes of Health
Grant: 3U10CA180821-02S2
Alliance for Clinical Trials in Oncology Operations Center
FWCI
0.00
Citation Percentile
0.1%
Fields of Study
Keywords
Sustainable Development Goals